Skip to main content

Table 1 MiRNAs that were differentially expressed between LVSI-positive and LVSI-negative ovarian cancer tissues

From: Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression

Downregulated miRNA LVSI(+)/LVSI(−) Fold change P value Adjusted P value Upregulated miRNA LVSI(+)/LVSI(−) Fold change P value Adjusted P value
hsa-miR-25 0.778 < 0.001 0.025 hsa-miR-142-5p 1.651 < 0.001 0.025
hsa-miR-96 0.614 0.002 0.143 hsa-miR-22 1.516 < 0.001 0.063
hsa-miR-183 0.700 0.004 0.161 hsa-miR-142-3p 1.600 < 0.001 0.065
hsa-miR-514 0.625 0.008 0.180 hsa-miR-21 1.272 < 0.001 0.065
hsa-miR-218 0.716 0.007 0.180 hsa-let-7b 1.334 0.001 0.082
hsa-miR-335 0.770 0.008 0.180 hsa-miR-21* 1.426 0.002 0.143
hsa-miR-509-5p 0.742 0.013 0.204 hsa-miR-199a-5p 1.444 0.005 0.180
hsa-miR-375 0.793 0.012 0.204 hsa-miR-150 1.388 0.004 0.180
hsa-miR-26b 0.758 0.015 0.222 hsa-miR-483-5p 1.324 0.008 0.180
hsa-miR-200a 0.747 0.016 0.225 hsa-miR-202 1.277 0.005 0.180
hsa-miR-125b 0.785 0.018 0.229 hsa-miR-199b-3p 1.373 0.012 0.204
hsa-miR-509-3p 0.719 0.026 0.276 hsa-miR-214 1.360 0.012 0.204
hsa-let-7e 0.793 0.029 0.284 hsa-miR-638 1.338 0.014 0.212
hsa-miR-507 0.782 0.039 0.312 hsa-miR-1225-5p 1.345 0.018 0.229
hsa-miR-99a 0.790 0.040 0.315 hsa-miR-188-5p 1.269 0.017 0.229
hsa-miR-509-3-5p 0.730 0.045 0.323 hsa-miR-222 1.265 0.024 0.267
     hsa-miR-144 1.355 0.028 0.284
     hsa-miR-223 1.330 0.030 0.286
  1. *is part of the name of a specific miRNA